Furthermore, AuNP treatment reduced myocardial mRNA and protein levels of TNF-α in diabetic cardiomyopathy (DCM), resulting in a reduced intramyocardial inflammatory response and cardiac collagen content [42]. The gene discussed is TNF; the disease is diabetic cardiomyopathy.